Publication details
Management of Metastatic Gastric Cancer
| Authors | |
|---|---|
| Year of publication | 2017 |
| Type | Article in Periodical |
| Magazine / Source | Hematology-Oncology Clinics of North America |
| MU Faculty or unit | |
| Citation | |
| Doi | http://dx.doi.org/10.1016/j.hoc.2017.01.006 |
| Keywords | Gastric cancer; Metastases; Chemotherapy; Radiotherapy; Surgery; Doublet; Triplet; Sequence |
| Description | Metastatic gastric cancer is an incurable disease. Systemic chemotherapy prolongs survival, improves symptom control, and helps maintain a better quality of life of patients with metastatic gastric cancer. HER2 testing of the primary tumor and/or the metastases is warranted before initiation of first line treatment. This review article outlines the indication and clinical data of medical treatment of advanced gastric cancer and highlights aspects of quality of life. |